- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Germany
Total 100 results
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Disease | Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Accelerated Phase of Disease | Chronic Phase of DiseaseUnited States, Germany, Italy
-
University of BonnPfizer; RWTH Aachen University; Ludwig-Maximilians - University of Munich; Heidelberg... and other collaboratorsUnknownChronic Myelogenous LeukaemiaGermany
-
PfizerCompletedLeukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) PositiveFrance, United States, Canada, Spain, Czechia, Singapore, Thailand, Denmark, Norway, Korea, Republic of, Finland, Hungary, Sweden, Netherlands, Italy, Germany, Ukraine, South Africa, Taiwan, Australia, Belgium, Israel, Mexico, Poland, S... and more
-
Cancer Trials IrelandCompletedLeukemiaUnited States, Ireland, Israel, Germany
-
Heidelberg UniversityCompleted
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Hodgkin Lymphoma | Recurrent Adult Acute Myeloid Leukemia | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent Non-Hodgkin Lymphoma | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Plasma Cell MyelomaUnited States, Germany, Italy
-
Novartis PharmaceuticalsTerminatedLeukemia, Myeloid, ChronicUnited States, Germany
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia | Blast CrisisNetherlands, United States, Italy, Austria, Canada, France, Germany, Singapore, Taiwan, United Kingdom, Australia, Korea, Republic of, Philippines, Sweden, Finland, Israel, Belgium, Denmark, Norway, Switzerland
-
Bristol-Myers SquibbCompletedChronic Myelogenous LeukemiaNetherlands, United States, Italy, Argentina, Brazil, Canada, Germany, Peru, Singapore, Taiwan, United Kingdom, France, Korea, Republic of, Philippines, Sweden, Thailand, Finland, Australia, Israel, Belgium, Denmark, Norway, Switzer...
-
Bristol-Myers SquibbCompletedMyeloid Leukemia, Chronic, Chronic-PhaseUnited States, Australia, France, Germany, Italy, Korea, Republic of, Sweden, Taiwan, Spain, Austria, Denmark, Belgium, Canada, Ireland, Switzerland, Netherlands, Peru, United Kingdom, South Africa, Argentina, Philippines, Singapore, Russian Federation and more
-
University of JenaNovartis Pharmaceuticals; Ludwig-Maximilians - University of MunichActive, not recruiting
-
University of JenaActive, not recruitingChronic Myeloid Leukemia, Chronic PhaseGermany
-
Bristol-Myers SquibbActive, not recruitingLeukemiaFrance, India, United States, Canada, Spain, Italy, Mexico, South Africa, United Kingdom, Korea, Republic of, Russian Federation, Australia, Argentina, Germany, Brazil, Netherlands, Romania, Singapore
-
Bristol-Myers SquibbCompletedChronic Phase Chronic Myeloid LeukemiaFrance, Italy, United States, Korea, Republic of, Germany
-
Bristol-Myers SquibbPPD; European Organisation for Research and Treatment of Cancer - EORTC; ICON... and other collaboratorsCompletedChronic Phase Chronic Myeloid LeukemiaUnited States, Canada, France, Germany, Italy, Spain
-
Johann Wolfgang Goethe University HospitalUnknownPhiladelphia Positive Acute Lymphoblastic Leukemia | Lymphoid Blastic Phase of Chronic Myeloid LeukemiaGermany
-
Incyte Biosciences International SàrlRecruitingLymphoma | Acute Myeloid Leukemia | Leukemia | Acute Lymphoblastic Leukemia | Acute Lymphocytic Leukemia | Solid Tumors | Chronic Phase Chronic Myeloid Leukemia | Accelerated Phase Chronic Myeloid Leukemia | Blast Phase Chronic Myeloid LeukemiaSpain, Italy, France, Germany, United Kingdom, Belgium, Sweden, Denmark, Netherlands
-
Novartis PharmaceuticalsTerminatedChronic Myeloid Leukemia in Chronic PhaseBelgium, Germany
-
Bristol-Myers SquibbTerminatedLeukemia, Myeloid, ChronicSweden, United Kingdom, Russian Federation, France, Germany, Belgium, Portugal, Finland, Norway, Spain, Italy
-
Goethe UniversityCompletedA Phase I, Dose-finding Study of BEZ235 in Adult Patients With Relapsed or Refractory Acute LeukemiaAcute Lymphoblastic Leukemia | Leukemia, Myelocytic, Acute | Chronic Myelogenous Leukemia With Crisis of Blast CellsGermany
-
Hoffmann-La RocheCompletedMyelogenous Leukemia, ChronicGermany
-
Onco Medical Consult GmbHCompletedTreating Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) With Dasatinib (DasPAQT)Myeloid Leukemia, Chronic, Chronic-PhaseGermany
-
University of JenaRecruitingChronic Myeloid Leukemia in Myeloid Blast CrisisGermany, Czechia, Russian Federation, Ukraine
-
Kerman University of Medical SciencesTerminatedChronic Myelogenous LeukemiaIran, Islamic Republic of
-
German CML Study GroupUnknown
-
TakedaActive, not recruitingMyeloid Leukemia, Chronic, Chronic PhaseUnited States, Spain, Taiwan, Australia, Canada, Russian Federation, Sweden, Switzerland, Germany, United Kingdom, Poland, Korea, Republic of, Argentina, Hong Kong, Singapore, Italy, Chile, Czechia, Denmark, France, Portugal
-
GWT-TUD GmbHIncyte Biosciences International SàrlTerminated
-
Novartis PharmaceuticalsCompletedPhiladelphia Chromosome Positive (PH+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)Germany, Belgium, France, Italy, Spain, Hungary, Austria, Sweden, Bulgaria, Denmark, Greece, Slovenia, United Kingdom, Czechia, Romania, Serbia, Slovakia, Portugal, Finland, Norway, Poland
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia | Leukemia, Lymphoblastic, Acute, Philadelphia-positiveNetherlands, United States, Italy, Argentina, Austria, Brazil, Canada, Germany, Peru, United Kingdom, France, Korea, Republic of, Sweden, Finland, Australia, Israel, Belgium, Denmark, Norway, Switzerland
-
Novartis PharmaceuticalsCompletedChronic Myelogenous LeukemiaChina, Argentina, Russian Federation, Germany, Guatemala, Panama, Colombia, Mexico, Brazil, India, Poland, Venezuela
-
European Society for Blood and Marrow TransplantationHoffmann-La Roche; AmgenCompletedAcute Leukemia | Myelodysplastic Syndrome | Chronic Myelogenous LeukemiaGermany
-
Novartis PharmaceuticalsCompletedPhiladelphia Chromosome Positive Chronic Myelogenous LeukemiaGermany, Canada, France, Spain, Italy
-
University Hospital Carl Gustav CarusCompletedChronic Myeloid LeukemiaGermany
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...CompletedHematopoietic and Lymphoid Cell Neoplasm | Diffuse Large B-Cell Lymphoma | Refractory Hodgkin Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Plasma Cell Myeloma | Refractory Chronic Lymphocytic Leukemia | Myelodysplastic/Myeloproliferative Neoplasm | Chronic Phase Chronic Myelogenous... and other conditionsUnited States, Germany, Italy
-
Novartis PharmaceuticalsCompletedPhiladelphia Chromosome Positive CMLUnited States, Germany, Italy, France
-
Charite University, Berlin, GermanyTerminated
-
Novartis PharmaceuticalsCompletedChronic Myeloid LeukemiaGermany
-
Novartis PharmaceuticalsCompletedChronic Myeloid LeukemiaUnited Kingdom, Germany
-
III. Medizinische Klinik MannheimUnknownLeukemiaSwitzerland, Germany, Spain, Poland, Czech Republic
-
Novartis PharmaceuticalsActive, not recruitingChronic Myelogenous LeukemiaSpain, United Kingdom, Germany, Canada, Austria, France, Korea, Republic of, Greece, Singapore, Italy, Argentina, Poland, Vietnam, Malaysia, Oman, Brazil
-
Novartis PharmaceuticalsActive, not recruitingChronic Myelogenous LeukemiaUnited States, United Kingdom, Hungary, Japan, Saudi Arabia, Australia, Germany, Canada, France, Netherlands, Spain, Lebanon, Turkey, Korea, Republic of, Argentina, Brazil, Bulgaria, Czechia, Israel, Italy, Mexico, Romania, Russian... and more
-
Technische Universität DresdenNordic Society for Pediatric Hematology and Oncology; Uniuversity of Genua,... and other collaboratorsUnknownMyeloid Leukemia, ChronicGermany
-
Novartis PharmaceuticalsTerminatedMyelogenous LeukemiaUnited States, Germany, Belgium, Italy, Spain, Korea, Republic of, Brazil, Japan, Australia, Czech Republic
-
Prof. Dr. Nikolas von BubnoffNovartisTerminated
-
Bristol-Myers SquibbCompletedLeukemia, Lymphoblastic, Acute, Philadelphia-Positive | Myeloid Leukemia, Chronic, Accelerated PhaseAustralia, Canada, France, Germany, Italy, Korea, Republic of, Taiwan, Thailand, United States, Spain, Austria, Denmark, Belgium, Sweden, Switzerland, Netherlands, Peru, South Africa, Philippines, Singapore, Russian Federation, Br... and more
-
Gesellschaft fur Medizinische Innovation - Hamatologie...Crolll GmbhCompletedChronic Myelogenous Leukemia (CML)Germany
-
Novartis PharmaceuticalsActive, not recruitingChronic Myelogenous LeukemiaBelgium, Spain, Austria, Germany, Italy, France, Netherlands, Sweden, Japan, United States, Greece, United Kingdom, Bulgaria, Hungary, Argentina, Poland, Colombia, Ireland, Denmark
-
Novartis PharmaceuticalsActive, not recruitingHematologic Diseases | Chronic Myelogenous Leukemia | CML | Leukemia, Myeloid ChronicTaiwan, Italy, Spain, United Kingdom, Germany, United States, Korea, Republic of, France, Russian Federation, Canada, Denmark, Poland, Portugal, Austria, Czechia
-
Novartis PharmaceuticalsRecruitingLeukemia, Myelogenous, Chronic, BCR-ABL Positive | Chronic Myelogenous LeukemiaDenmark, Spain, France, Germany, Lebanon, Italy, Argentina, Czechia, Portugal, United Kingdom, Brazil, Mexico, Russian Federation, Taiwan, Austria, Canada, Korea, Republic of, Turkey, United States, Singapore, Japan, Bulgaria, Poland, Romani... and more
-
Thomas Ernst, PD Dr. med.AbbVie; Ludwig-Maximilians - University of MunichRecruitingChronic Myeloid LeukemiaGermany